Advanced in vivo heteronuclear MRS approaches for studying brain bioenergetics driven by mitochondria

Methods in Molecular Biology

Volumn 489, Issue , 2009, Pages 317-357

  Zhu, Xiao Hong ^a   Du, Fei ^a   Zhang, Nanyin ^a   Zhang, Yi ^a   Lei, Hao ^b   Zhang, Xiaoliang ^a   Qiao, Hongyan ^a   Ugurbil, Kamil ^a   Chen, Wei ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Wuhan National Laboratory for Optoelectronics   (China)

Author keywords

Brain; Brain function; Brain metabolism; Cerebral bioenergetics; In vivo 17O MRS; In vivo 31P MRS; In vivo heteronuclear MRS; Magnetic field; MRI

Indexed keywords

ANIMALIA;

EID: 84934435318     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-543-5_15     Document Type: Review

References (153)

1. Boyer PD. What makes ATP synthase spin? Nature 1999;402(6759):247, 249.
2. Stock D, Leslie AG, Walker JE. Molecular architecture of the rotary motor in ATP synthase. Science 1999;286(5445):1700-1705.
3. Siesjo BK. Brain energy metabolism. New York: Wiley; 1978. p 101-110.
4. Raichle ME. Circulatory and metabolic correlates of brain function in normal humans. In: Mountcastle VB, Plum F, Geiger SR, editors. Handbook of Physiology-The Nervous System. Bethesda: American Physiological Society; 1987. p 643-674.
5. Clarke DD, Sokoloff L. Circulation and energy metabolism of the brain. In: Siegel GJ, al. e, editors. Basic Neruochemistry: Molecular, Cellular and Medical Aspects. Philadephia: Lippincott-Raven Publishers; 1999. p 633-669.
6. Shulman RG, Rothman DL, Behar KL, Hyder F. Energetic basis of brain activity: Implications for neuroimaging. Trends Neurosci 2004;27(8):489-495.
7. Hyder F, Patel AB, Gjedde A, Rothman DL, Behar KL, Shulman RG. Neuronalglial glucose oxidation and glutamatergic-GABAergic function. J Cereb Blood Flow Metab 2006;26(7):865-877.
8. Raichle ME, Mintun MA. Brain work and brain imaging. Annu Rev Neurosci 2006;29:449-476.
9. Hevner RF, Wong-Riley MT. Regulation of cytochrome oxidase protein levels by functional activity in the macaque monkey visual system. J Neurosci 1990;10(4):1331-1340.
10. +-ATPase. Neurosci Lett 1992;138(1): 188-192.
11. Rolfe DF, Brown GC. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev 1997;77(3):731-758.
12. Attwell D, Laughlin SB. An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 2001;21(10):1133-1145.
13. Shulman RG, Rothman DL, Hyder F. Stimulated changes in localized cerebral energy consumption under anesthesia. Proc Natl Acad Sci USA 1999;96(6): 3245-3250.
14. Magistretti PJ, Pellerin L, Rothman DL, Shulman RG. Energy on demand. Science 1999;283(5401):496-497.
15. Wallimann T, Hemmer W. Creatine kinase in non-muscle tissues and cells. Mol Cell Biochem 1994;133-134:193-220.
16. Saks VA, Ventura-Clapier R, Aliev MK. Metabolic control and metabolic capacity: Two aspects of creatine kinase functioning in the cells. Biochim Biophys Acta 1996;1274(3):81-88.
17. Kemp GJ. Non-invasive methods for studying brain energy metabolism: what they show and what it means. Dev Neurosci 2000;22(5-6):418-428.
18. 13C nuclear magnetic resonance. Science 1979;205(4402):160-166.
19. 31P NMR using surface coils. Nature 1980;283:167-170.
20. 31P magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 2003;100:14409-14414.
21. Gadian DG, Williams SR, Bates TE, Kauppinen RA. NMR spectroscopy: current status and future possibilities. Acta Neurochir Suppl (Wien) 1993;57:1-8.
22. Weiner MW. NMR spectroscopy for clinical medicine. Animal models and clinical examples. Ann N Y Acad Sci 1987;508:287-299.
23. Hossmann KA. Studies of experimental cerebral ischemia with NMR spectroscopy. Arzneimittelforschung 1991;41(3A):292-298.
24. Lei H, Zhu XH, Zhang XL, Ugurbil K, Chen W. In vivo 31P magnetic resonance spectroscopy of human brain at 7 T: An initial experience. Magn Reson Med 2003;49:199-205.
25. 31P nuclear magnetic resonance spectroscopy. Neurology 1985;35(6):781-788.
26. Burt CT, Ribolow HJ. A hypothesis: Noncyclic phosphodiesters may play a role in membrane control. Biochem Med 1984;31(1):21-30.
27. Burt CT, Ribolow H. Glycerol phosphorylcholine (GPC) and serine ethanolamine phosphodiester (SEP): Evolutionary mirrored metabolites and their potential metabolic roles. Comp Biochem Physiol Biochem Mol Biol 1994;108(1):11-20.
28. Ross BM, Moszczynska A, Blusztajn JK, Sherwin A, Lozano A, Kish SJ. Phospholipid biosynthetic enzymes in human brain. Lipids 1997;32(4):351-358.
29. Podo F. Tumour phospholipid metabolism. NMR Biomed 1999;12(7):413-439.
30. 1H NMR study. Pediatr Res 1989;25(1):27-31.
31. Welch KM, Levine SR, Martin G, Ordidge R, Vande Linde AM, Helpern JA. Magnetic resonance spectroscopy in cerebral ischemia. Neurol Clin 1992;10(1):1-29.
32. Duncan JS. Imaging and epilepsy. Brain 1997;120(Pt 2):339-377.
33. 31P spectroscopy and bioenergetics in the lateralization of seizures in temporal lobe epilepsy. J Magn Reson Imaging 2002;16(4):477-483.
34. 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia. Neurology 1989;39(11):1423-1427.
35. Pettegrew JW, Klunk WE, Panchalingam K, McClure RJ, Stanley JA. Magnetic resonance spectroscopic changes in Alzheimer's disease. Ann N Y Acad Sci 1997;826:282-306.
36. Riehemann S, Volz HP, Smesny S, Hubner G, Wenda B, Rossger G, Sauer H. Phosphorus 31 magnetic resonance spectroscopy in schizophrenia research. Pathophysiology of cerebral metabolism of high-energy phosphate and membrane phospholipids. Nervenarzt 2000;71(5):354-363.
37. 31P-MRS study at 4.0 Tesla. Br J Psychiatry 2002;180:39-44.
38. Ramadan NM, Halvorson H, Vande-Linde A, Levine SR, Helpern JA, Welch KM. Low brain magnesium in migraine. Headache 1989;29(9):590-593.
39. Altura BM, Altura BT. Role of magnesium and calcium in alcohol-induced hypertension and strokes as probed by in vivo television microscopy, digital image microscopy, optical spectroscopy, 31P-NMR, spectroscopy and a unique magnesium ion-selective electrode. Alcohol Clin Exp Res 1994;18(5):1057-1068.
40. 31P magnetic resonance spectroscopy study of cerebral metabolism in developing dog brain and its relationship to neuronal function. Dev Neurosci 1991;13(2):61-68.
41. Nioka S, Smith DS, Mayevsky A, Dobson GP, Veech RL, Subramanian H, Chance B. Age dependence of steady state mitochondrial oxidative metabolism in the in vivo hypoxic dog brain. Neurol Res 1991;13(1):25-32.
42. Chance B, Leigh JS, Jr., Nioka S, Sinwell T, Younkin D, Smith DS. An approach to the problem of metabolic heterogeneity in brain: Ischemia and reflow after ischemia. Ann N Y Acad Sci 1987;508:309-320.
43. Frosen S, Hoffman RA. Study of moderately rapid chemical exchange by means of nuclear magnetic double resonance. J Chem Phys 1963;39:2892-2901.
44. Alger JR, Shulman RG. NMR Studies of enzymatic rates in vitro and in vivo by magnetization transfer. Quart Rev Biophys 1984;17:83-124.
45. Ugurbil K. Magnetization transfer measurements of individual rate constants in the presence of multiple reactions. J Magn Reson 1985;64:207-219.
46. Ugurbil K. Magnetization transfer measurements of creatine kinase and ATPase rates in intact hearts. Circulation 1985;72(Supp. IV):IV94- IV96.
47. 31P NMR saturation- and inversiontransfer study. Biochemistry 1985;24(20):5510-5516.
48. Bottomley PA, Ouwerkerk R, Lee RF, Weiss RG. Four-angle saturation transfer (FAST) method for measuring creatine kinase reaction rates in vivo. Magn Reson Med 2002;47(5):850-863.
49. 31P NMR saturation transfer measurements of the steady state rates of creatine kinase and ATP synthetase in the rat brain. FEBS Lett 1982;140(2):289-292.
50. 31P magnetization transfer approach for noninvasively determining multiple kinetic parameters and metabolic fluxes of ATP metabolism in the human brain. Magn Reson Med 2006;57(1):103-114.
51. Mateescu GD, Yvars GM, Dular T. Water, Ions and O-17 Magnetic Resonance Imaging. In: Lauger P, Packer L, Vasilescu V, editors. Water and Ions in Biological Systems. Basel-Boston-Berlin: Birkhauser Verlag; 1988. p 239-250.
52. 17O magnetic resonance imaging. Magn Reson Med 1991;21(2):313-319.
53. 2 inhalation. Magn Reson Med 1992;24(2):370-374.
54. 17O NMR approach for fast imaging of cerebral metabolic rate of oxygen in rat brain at high field. Proc Natl Acad Sci U S A 2002;99(20):13194-13199.
55. 17O NMR approaches for brain study at high field. NMR Biomed 2005;18(2):83-103.
56. Ernst RR, Bodenhausen G, Wokaun A. Principles of Nuclear Magnetic Resonance in One and Two Dimensions. New York: Oxford University Press; 1991.
57. Hoult DI, Richards RE. The signal-to-noise ratio of nuclear magnetic resonance experiment. J Magn Reson 1976;24:71-85.
58. Wen H, Chesnick AS, Balaban RS. The design and test of a new volume coil for high field imaging. Magn Reson Med 1994;32:492-498.
59. Wang Z, Wang DJ, Noyszewski EA, Bogdan AR, Haselgrove JC, Reddy R, Zimmerman RA, Leigh JS. Sensitivity of in vivo MRS of the N-δ proton in proximal histidine of deoxymyoglobin. Magn Reson Med 1992;27(2):362-367.
60. 31P MRS of human brain at high/ultrahigh fields: A quantitative comparison of NMR detection sensitivity and spectral resolution between 4 T and 7 T. Magn Reson Imaging 2006;24(10):1281-1286.
61. 1H MRI at 1.5 and 2.0 T. Magn Reson Med 1990;13(2):228-238.
62. 31P spectroscopy on a 4-T whole-body system. Magn Reson Med 1988;8(1):104-109.
63. 31P spectroscopic imaging of human brain at 4 Tesla: assessment of gray and white matter differences of phosphocreatine and ATP. Magn Reson Med 2001;45:46-52.
64. 31P spin-lattice relaxation times and resonance linewidths of rat tissue in vivo: Dependence upon the static magnetic field strength. Magn Reson Med 1985;2(4):410-417.
65. 31P metabolites in model solutions at two frequencies: Implications for in vivo spectroscopy. Magn Reson Imaging 1990;8(6):691-698.
66. Abragam A. The Principles of Nuclear Magnetism. Mott NF, Bullard EC, Wilkinson DH, editors. London: Oxford University Press; 1961.
67. 17O relaxation time and NMR sensitivity of cerebral water and their field dependence. Magn Reson Med 2001;45(4):543-549.
68. 2 and SNR - in vitro and in vivo studies at 4.7, 11 and 17.6 Tesla. In: Proc Intl Soc Mag Reson Med (ISMRM) 2003; Toronto. p 504.
69. 1H magnetic resonance imaging in plants, animals, and materials. In: Baillie TA, Jones JR, editors. Synthesis and Application of Isotopically Labeled Compounds. Amsterdam: Elsevier; 1989. p 499-508.
70. 17O on protein solutions and living tissues. Magn Reson Med 1987;4(4):399-403.
71. 17O. Magn Reson Med 1991;22(1):154-158.
72. Arai T, Nakao S, Mori K, Ishimori K, Morishima I, Miyazawa T, Fritz-Zieroth B. Cerebral oxygen utilization analyzed by the use of oxygen-17 and its nuclear magnetic resonance. Biochem Biophys Res Commun 1990;169(1):153-158.
73. 19F magnetic resonance imaging. J Cereb Blood Flow Metab 1995;15(2):312-320.
74. 17O with potential applications for functional MRI. Magn Reson Med 1994;32(6):789-793.
75. 17O MRI. Proc Natl Acad Sci U S A 1998;95(22):12934-12939.
76. 1 rho dispersion imaging. J Magn Reson B 1995;108(3):276-279.
77. 17O NMR approach at ultra-high field. In: Shulman RG, Rothman DL, editors. Brain Energetics and Neuronal Activity. New York: John Wiley & Sons Ltd; 2004. p 125-146.
78. Arai T, Mori K, Nakao S, Watanabe K, Kito K, Aoki M, Mori H, Morikawa S, Inubushi T. In vivo oxygen-17 nuclear magnetic resonance for the estimation of cerebral blood flow and oxygen consumption. Biochem Biophys Res Commun 1991;179(2):954-961.
79. 17O in vivo NMR spectroscopy and magnetic resonance imaging: Part 1. Theory and data analysis methods. Neurol Res 1992;14(4):303-311.
80. 17O natural abundance cerebral magnetic resonance imaging and spectroscopy in a whole body system. Neurol Res 1993;15(4):237-248.
81. 17O MRI. Neurol Res 1993;15(1):7-22.
82. Mateescu GD. Functional oxygen-17 magnetic resonance imaging and localized spectroscopy. Adv Exp Med Biol 2003;510:213-218.
83. 17O-ecoupled proton MR spectroscopy and imaging in a tissue model. J Magn Reson 1997;125(1):1-7.
84. 17O-decoupled 1H detection using a double-tuned coil. Magn Reson Imaging 1996;14(9):1073-1078.
85. 17O-labeled water. Magn Reson Med 2000;43(6):876-883.
86. 2 in rats at 9.4 T: Reproducibility test and normothermia/ hypothermia comparison study. J Cereb Blood Flow Metab 2007;27(6):1225-1234.
87. 2 inhalation. J Cereb Blood Flow Metab 2004;24(8):840-848.
88. Ter-Pogossian MM, Eichling JO, Davis DO, Welch MJ. The measure in vivo of regional cerebral oxygen utilization by means of oxyhemoglobin labeled with radioactive oxygen-15. J Clin Invest 1970;49:381-391.
89. Lenzi GL, Jones T, Frackowiak RS. Positron emission tomography: state of the art in neurology. Prog Nucl Med 1981;7:118-137.
90. Mintun MA, Raichle ME, Martin WR, Herscovitch P. Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography. J Nucl Med 1984;25(2): 177-187.
91. Fox PT, Raichle ME, Mintun MA, Dence C. Nonoxidative glucose consumption during focal physiologic neural activity. Science 1988;241:462-464.
92. Kety SS, Schmidt CF. The determination of cerebral blood flow in man by the use of nitrous oxide in low concentrations. Am J Physiol 1945;143:53-66.
93. Kety SS, Schmidt CF. Nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure and normal values. J Clin Invest 1948;27:476-483.
94. Kety SS, Schmidt CF. Effects of altered arterial tensions of carbon dioxide and oxygen on cerebral blood flow and cerebral oxygen consumption of normal young men. J Clin Invest 1948;27:484-492.
95. Herscovitch A, Raichle ME. What is the correct value for the brain-blood partition coefficient for water? J Cereb Blood Flow Metab 1985;5:65-69.
96. Herscovitch P, Raichle ME, Kilbourn MR, Welch MJ. Positron emission tomographic measurement of cerebral blood flow and permeability-surface area product of water using [15O]water and [11C]butanol. J Cereb Blood Flow Metab 1987;7(5):527-542.
97. 17O water tracer in rat carotid artery by using a region-defined (REDE) implanted vascular RF coil. Magma 2003;16(2):77-85.
98. Nakao Y, Itoh Y, Kuang TY, Cook M, Jehle J, Sokoloff L. Effects of anesthesia on functional activation of cerebral blood flow and metabolism. Proc Natl Acad Sci U S A 2001;98(13):7593-7598.
99. Hyder F, Kennan RP, Kida I, Mason GF, Behar KL, Rothman D. Dependence of oxygen delivery on blood flow in rat brain: A 7 tesla nuclear magnetic resonance study. J Cereb Blood Flow Metab 2000;20(3):485-498.
100. 15O-labelled oxygen gas. Nucl Med Commun 2006;27(7): 573-581.
101. 17O MR approach. In: Proc Intl Soc Mag Reson Med (ISMRM), 2006; Seattle. p 952.
102. Erecinska M, Thoresen M, Silver IA. Effects of hypothermia on energy metabolism in Mammalian central nervous system. J Cereb Blood Flow Metab 2003;23(5):513-530.
103. Weiss RG, Gerstenblith G, Bottomley PA. ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci U S A 2005;102(3):808-813.
104. Balaban RS, Kantor HL, Ferretti JA. In vivo flux between phosphocreatine and adenosine triphosphate determined by two-imensional phosphorous NMR. J Biol Chem 1983;258(21):12787-12789.
105. 31P magnetization transfer studies of creatine kinase kinetics in living rabbit brain. Magn Reson Med 1987;5(1):1-12.
106. 31P NMR. J Magn Reson 1992;99:443-448.
107. Sauter A, Rudin M. Determination of creatine kinase parameters in rat brain by NMR magnetization transfer. J Biological Chem 1993;268:13166-13171.
108. 31P NMR magnetization transfer study. Magn Reson Med 1997;38:551-557.
109. Braunova Z, Kasparova S, Mlynarik V, Mierisova S, Liptaj T, Tkac I, Gvozdjakova A. Metabolic changes in rat brain after prolonged ethanol consumption measured by 1H and 31P MRS experiments. Cell Mol Neurobiol 2000;20(6):703-715.
110. 31P NMR saturation transfer. 13th Proc Intl Soc Mag Reson Med 2005:2767.
111. Joubert F, Mateo P, Gillet B, Beloeil JC, Mazet JL, Hoerter JA. CK flux or direct ATP transfer: Versatility of energy transfer pathways evidenced by NMR in the perfused heart. Mol Cell Biochem 2004;256-257(1-2):43-58.
112. 31P-NMR saturation transfer study of the regulation of creatine kinase in the rat heart. Biochim Biophys Acta 1982;721(3):312-320.
113. 31P magnetization transfer studies in the monkey brain. Magn Reson Med 1992;26(1):100-115.
114. 31P NMR surface coil studies in brain, heart, and skeletal muscle of the living rat. Biochemistry 1987;26:6083-6090.
115. Ugurbil K, Petein M, Maiden R, Michurski S, From A. Measurement of an individual rate constant in the presence of multiple exchanges: Application to myocardial creatine kinase rates. Biochemistry 1986;25:100-108.
116. Spencer RG, Balschi JA, Leigh JS, Jr., Ingwall JS. ATP synthesis and degradation rates in the perfused rat heart. 31P-nuclear magnetic resonance double saturation transfer measurements. Biophys J 1988;54(5): 921-929.
117. Joubert F, Mazet JL, Mateo P, Hoerter JA. 31P NMR detection of subcellular creatine kinase fluxes in the perfused rat heart: Contractility modifies energy transfer pathways. J Biol Chem 2002;277(21):18469-18476.
118. 31P-NMR saturation transfer studies of aerobic Escherichia coli cells. Biochimica et Biophysica Acta 1988;969(2):185-193.
119. 31P NMR saturation-transfer measurements in Saccharomyces cerevisiae: Characterization of phosphate exchange reactions by iodoacetate and antimycin A inhibition. Biochemistry 1987;26(23):7483-7492.
120. Thoma WJ, Ugurbil K. Saturation-transfer studies of ATP-Pi exchange in isolated perfused rat liver. Biochimica et Biophysica Acta 1987;893(2):225-231.
121. Kingsley-Hickman PB, Sako EY, Mohanakrishnan P, Robitaille PM, From AH, Foker JE, Ugurbil K. 31P NMR studies of ATP synthesis and hydrolysis kinetics in the intact myocardium. Biochemistry 1987;26(23):7501-7510.
122. Hinkle PC. P/O ratios of mitochondrial oxidative phosphorylation. Biochim Biophys Acta 2005;1706(1-2):1-11.
123. 31P magnetization transfer and electroencephalograph measurement. In: Proc Intl Soc Mag Reson Med (ISMRM), 2006; Seattle. p 2125.
124. Fox PT, Raichle ME. Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci USA 1986; 83:1140-1144.
125. Ribeiro L, Kuwabara H, Meyer E, Fujita H, Marrett S, Evans A, Gjedde A. Cerebral blood flow and metabolism during nonspecific bilateral visual stimulation in normal subjects. In: Uemura K, editor. Quantification of Brain Function in Tracer Kinetics and Image Analysis in Brain PET. New York: Elsevier Science; 1993. p 229-236.
126. Roland PE, Ericksson L, Stone-Elander S, Widen L. Does mental activity change the oxidative metabolism of the brain? J Neurosci 1987;7:2373-2389.
127. Marrett S, Fujita H, Meyer E, Ribeiro L, Evans A, Kuwabara H, Gjedde A. Stimulus specific increase of oxidative metabolism in human visual cortex. In: Uemura K, editor. Quantification of Brain Function in Tracer Kinetics and Image Analysis in Brain PET. New York: Elsevier Science; 1993. p 217-228.
128. 1H NMR in human visual cortex during physiologic stimulation. Proc Natl Acad Sci (USA) 1992;88:5829-5831.
129. Shulman RG, Hyder F, Rothman DL. Cerebral energetics and the glycogen shunt: neurochemical basis of functional imaging. Proc Natl Acad Sci U S A 2001;98(11):6417-6422.
130. Vafaee MS, Meyer E, Marrett S, Paus T, Evans AC, Gjedde A. Frequency-dependent changes in cerebral metabolic rate of oxygen during activation of human visual cortex. J Cereb Blood Flow Metab 1999;19(3):272-277.
131. Davis TL, Kwong KK, Weisskoff RM, Rosen BR. Calibrated functional MRI: Mapping the dynamic of oxidative metabolism. Proc Natl Acad Sci USA 1998;95:1834-1839.
132. Hoge RD, Atkinson J, Gill B, Crelier GR, Marrett S, Pike GB. Investigation of BOLD signal dependence on cerebral blood flow and oxygen consumption: The deoxyhemoglobin dilution model [In Process Citation]. Magn Reson Med 1999;42(5):849-863.
133. 13C} NMR. Proc Natl Acad Sci USA 1996;93:7612-7617.
134. Kim SG, Rostrup E, Larsson HB, Ogawa S, Paulson OB. Determination of relative CMRO2 from CBF and BOLD changes: Significant increase of oxygen consumption rate during visual stimulation. Magn Reson Med 1999;41(6):1152-1161.
135. 13C} MRS and fMRI. Magn Reson Med 2001;45:349-355.
136. Kasischke KA, Vishwasrao HD, Fisher PJ, Zipfel WR, Webb WW. Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis. Science 2004;305(5680):99-103.
137. Ogawa S, Lee T-M, Kay AR, Tank DW. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci USA 1990;87:9868-9872.
138. Ogawa S, Tank DW, Menon R, Ellermann JM, Kim S-G, Merkle H, Ugurbil K. Intrinsic signal changes accompanying sensory stimulation: Functional brain mapping with magnetic resonance imaging. Proc Natl Acad Sci USA 1992; 89:5951-5955.
139. Kwong KK, Belliveau JW, Chesler DA, Goldberg IE, Weisskoff RM, Poncelet BP, Kennedy DN, Hoppel BE, Cohen MS, Turner R, Cheng HM, Brady TJ, Rosen BR. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci USA 1992;89:5675-5679.
140. Bandettini PA, Wong EC, Hinks RS, Tikofsky RS, Hyde JS. Time course EPI of human brain function during task activation. Magn Reson Med 1992;25:390-397.
141. Frahm J, Bruhn H, Merboldt KD, Hanicke W. Dynamic MR imaging of human brain oxygenation during rest and photic stimulation. J Magn Reson Imag 1992;2(5):501-505.
142. Blamire AM, Ogawa S, Ugurbil K, Rothman D, McCarthy G, Ellermann JM, Hyder F, Rattner Z, Shulman RG. Dynamic mapping of the human visual cortex by high-speed magnetic resonance imaging. Proc Natl Acad Sci USA 1992;89:11069-11073.
143. Barinaga M. What makes brain neurons run. Science 1997;276:196-198.
144. 2 in cat visual cortex at rest and visual stimulation. In: Proc Intl Soc Mag Reson Med (ISMRM), 2006; Seattle. p 457.
145. 31P MRS at 7T. In: Proc Intl Soc Mag Reson Med (ISMRM), 2004; Kyoto, Japan. p 2361.
146. Maurer I, Zierz S, Moller H. Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr Res 2001;48(1):125-136.
147. Wong-Riley M, Antuono P, Ho KC, Egan R, Hevner R, Liebl W, Huang Z, Rachel R, Jones J. Cytochrome oxidase in Alzheimer's disease: Biochemical, histochemical, and immunohistochemical analyses of the visual and other systems. Vision Res 1997;37(24):3593-3608.
148. Maurer I, Zierz S, Moller HJ. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging 2000;21(3):455-462.
149. Frackowiak RS, Herold S, Petty RK, Morgan-Hughes JA. The cerebral metabolism of glucose and oxygen measured with positron tomography in patients with mitochondrial diseases. Brain 1988;111(Pt 5):1009-1024.
150. Beal MF. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 1992;31(2):119-130.
151. Wallace DC. Mitochondrial genetics: A paradigm for aging and degenerative diseases? Science 1992;256(5057):628-632.
152. Wallace DC. Mitochondrial diseases in man and mouse. Science 1999;283(5407):1482-1488.
153. Ugurbil K, Adriany G, Akgün C, Andersen P, Chen W, Garwood M, Gruetter R, Henry P-G, Marjanska M, Moeller S, Van de Moortele P-F, Prüssmann K, Tkac I, Vaughan JT, Wiesinger F, Yacoub E, Zhu X-H. High Magnetic Fields for Imaging Cerebral Morphology, Function and Biochemistry. In: Robitaille PMLaB, L.J., editor. Biological Magnetic Resonance: Ultra High Field Magnetic Resonance Imaging. Volume 26. New York: Springer; 2006. p 285-342.